Literature DB >> 16549056

The novel human gene MIP functions as a co-activator of hMafF.

Xiaoxia Ye1, Yang Li, Qiang Huang, Yao Yu, Hanying Yuan, Ping Wang, Dafang Wan, Jianren Gu, Keke Huo, Yu-Yang Li, Hong Lu.   

Abstract

The human transcription factor MafF (hMafF) lacks a transactivation domain, it contains a heptad-leucine repeat motif (viz., Leu-zipper) that may mediate protein-protein interactions to regulate transcriptional activities. A protein with a coiled-coil domain encoded by a novel human gene (GenBank Accession No. AF289559) was found to interact with hMafF in vitro and in vivo and is designated as a MafF interacting protein (MIP). Here, we provide evidence that the coiled-coil domain of MIP is essential for binding to the Leu-zipper of hMafF and that the interaction between MIP and hMafF causes the translocalization of MIP from cytoplasm to nucleolus in HELA cells. We used a promoter-reporter system containing six tandem repeats of the US2 element, located in the promoter of the human oxytocin receptor gene and reported to bind specifically to hMafF, to understand effects on transcriptional activation of hMafF, and its interaction with MIP. Expression of hMafF or MIP alone did not alter basal reporter transcription activity, whereas co-expression of hMafF and MIP activated transcription efficiently. Moreover, truncated MIP, still containing the coiled-coil domain, transactivated as well as the full-length MIP did, and highlighting that MIP acts as a co-activator of hMafF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549056     DOI: 10.1016/j.abb.2006.02.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

1.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

2.  RBFOX1 Regulates the Permeability of the Blood-Tumor Barrier via the LINC00673/MAFF Pathway.

Authors:  Shuyuan Shen; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yunhui Liu; Libo Liu; Jun Ma; Teng Ma; Ping An; Yang Lin; Heng Cai; Di Wang; Zhen Li; Lini Zhao; Yixue Xue
Journal:  Mol Ther Oncolytics       Date:  2020-03-30       Impact factor: 7.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.